Logo image of LEJU

LEJU HOLDINGS LTD-ADR (LEJU) Stock Fundamental Analysis

USA - NYSE:LEJU - US50187J2078 - ADR

1.0824 USD
-0.02 (-1.6%)
Last: 4/11/2024, 8:04:00 PM
Fundamental Rating

1

Taking everything into account, LEJU scores 1 out of 10 in our fundamental rating. LEJU was compared to 64 industry peers in the Real Estate Management & Development industry. LEJU has a bad profitability rating. Also its financial health evaluation is rather negative. LEJU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LEJU has reported negative net income.
The reported net income has been mixed in the past 5 years: LEJU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: LEJU reported negative operating cash flow in multiple years.
LEJU Yearly Net Income VS EBIT VS OCF VS FCFLEJU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -50.40%, LEJU is doing worse than 86.76% of the companies in the same industry.
LEJU's Return On Equity of -269.46% is on the low side compared to the rest of the industry. LEJU is outperformed by 77.94% of its industry peers.
Industry RankSector Rank
ROA -50.4%
ROE -269.46%
ROIC N/A
ROA(3y)-24.34%
ROA(5y)-14.81%
ROE(3y)-87.27%
ROE(5y)-52.57%
ROIC(3y)N/A
ROIC(5y)N/A
LEJU Yearly ROA, ROE, ROICLEJU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

LEJU has a Gross Margin of 91.08%. This is amongst the best in the industry. LEJU outperforms 95.59% of its industry peers.
LEJU's Gross Margin has improved in the last couple of years.
LEJU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.74%
LEJU Yearly Profit, Operating, Gross MarginsLEJU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

LEJU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LEJU has more shares outstanding
Compared to 1 year ago, LEJU has a worse debt to assets ratio.
LEJU Yearly Shares OutstandingLEJU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
LEJU Yearly Total Debt VS Total AssetsLEJU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -5.46, we must say that LEJU is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LEJU (-5.46) is worse than 89.71% of its industry peers.
There is no outstanding debt for LEJU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.46
ROIC/WACCN/A
WACC7.55%
LEJU Yearly LT Debt VS Equity VS FCFLEJU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.91 indicates that LEJU may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.91, LEJU is doing worse than 70.59% of the companies in the same industry.
LEJU has a Quick Ratio of 0.91. This is a bad value and indicates that LEJU is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.91, LEJU is doing worse than 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
LEJU Yearly Current Assets VS Current LiabilitesLEJU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.60% over the past year.
Looking at the last year, LEJU shows a very negative growth in Revenue. The Revenue has decreased by -35.74% in the last year.
LEJU shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.09% yearly.
EPS 1Y (TTM)40.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.32%
Revenue 1Y (TTM)-35.74%
Revenue growth 3Y-20.87%
Revenue growth 5Y-1.09%
Sales Q2Q%-6.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LEJU Yearly Revenue VS EstimatesLEJU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M
LEJU Yearly EPS VS EstimatesLEJU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 0 5 -5

0

4. Valuation

4.1 Price/Earnings Ratio

LEJU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LEJU Price Earnings VS Forward Price EarningsLEJU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LEJU Per share dataLEJU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LEJU!.
Industry RankSector Rank
Dividend Yield N/A

LEJU HOLDINGS LTD-ADR

NYSE:LEJU (4/11/2024, 8:04:00 PM)

1.0824

-0.02 (-1.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-08 2024-04-08
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap149.20M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 4.48
P/tB 5.7
EV/EBITDA N/A
EPS(TTM)-6.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.49
BVpS0.24
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.4%
ROE -269.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.08%
FCFM N/A
ROA(3y)-24.34%
ROA(5y)-14.81%
ROE(3y)-87.27%
ROE(5y)-52.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.74%
F-ScoreN/A
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -5.46
F-ScoreN/A
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)6.73%
Cap/Depr(5y)15.71%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.74%
Revenue growth 3Y-20.87%
Revenue growth 5Y-1.09%
Sales Q2Q%-6.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-163.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-170.68%
OCF growth 3YN/A
OCF growth 5YN/A